Atlas Trials

Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)

Clinical trial NCT07035405 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07035405
Sponsor
Beijing Tiantan Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Stroke
Start date
2025-07-04
Primary completion
2028-12-31
Enrollment
7500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.